直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

At the PTAB Blog

Can a Declaratory Judgment Plaintiff File a CBM Petition?

June 18, 2013

Authored and Edited by Kathleen A. Daley

While the Transitional Program for Post Grant Review of Covered Business Method (“CBM”) proceedings and Post Grant Review (“PGR”) proceedings are governed by many of the same statutory and regulatory provisions, several distinctions exist between them. One of those appears to be whether a declaratory judgment plaintiff in a corresponding civil suit may file a petition.

The statute and regulations on PGR make clear that a declaratory judgment plaintiff may not file a petition for PGR. In particular, 35 U. S. C. § 325(a)(1) states that a “post-grant review may not be instituted .  .  .  if, before the date on which the petition for such review is filed, the petitioner or real party in interest filed a civil action challenging the validity of a claim of the patent. ” 37 C. F. R. § 42. 201(a), which governs “[w]ho may petition for a post-grant review,” mirrors this language.

By contrast, 37 C. F. R.  § 42. 302(a), which governs “[w]ho may petition for a covered business method patent review,” provides:

A petitioner may not file with the Office a petition to institute a covered business method patent review of the patent unless the petitioner, the petitioner’s real party-in-interest, or a privy of the petitioner has been sued for infringement of the patent or has been charged with infringement under that patent. Charged with infringement means a real and substantial controversy regarding infringement of a covered business method patent exists such that the petitioner would have standing to bring a declaratory judgment action in Federal court.

(Emphasis added). This regulation does not preclude a declaratory judgment plaintiff from filing a petition for CBM.

Of note, the AIA, in section 18(a)(1) provides that CBM proceedings “shall be regarded as, and shall employ the standards and procedures of, a post-grant review” subject to certain exceptions.  Section § 325(a) of the statute, which provides that declaratory judgment plaintiffs may not file for PGR, is not among the listed exceptions.

In contrast, the USPTO’s rules covering CBMs do except the rule precluding a declaratory judgment plaintiff from filing a PGR. Specifically, 37 C. F. R. 42. 300(a) provides that a “covered business method patent review is a trial subject to the procedures set forth in subpart A of this part and is also subject to the post-grant review procedures set forth in subpart C except for §§42. 200, 42. 201, 42. 202, and 42. 204. ” (emphasis added). As a result, the USPTO’s rules do not bar a declaratory judgment plaintiff from filing a CBM petition. The USPTO has commented that it believes “[t]his is consistent with section 18(a)(1) of the AIA, which provides that the transitional proceeding shall be regarded as, and shall employ the standards and procedures of, a post-grant review with certain exceptions. ” See 77 Fed. Reg. 48693.

To date, only one DJ plaintiff has filed a CBM petition.  See SAP America, Inc.  v.  Pi-Net International, Inc., CBM2013-00013 (filed Mar.  22, 2013). The patent owner has not yet filed a preliminary response in that proceeding, nor has the USPTO issued a decision regarding grant.

Tags

declaratory judgment action

Contacts

Kathleen A. Daley
Partner
Washington, DC
+1 202 408 4098
Email

Copyright © 2013 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. 

DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. Additional disclaimer information. 

Related Insights

Reception

2026 IPO Education Foundation Awards Dinner

December 15, 2026

Washington, DC

Conference

2026 AIPLA Annual Meeting

October 29-31, 2026

Washington, DC

Conference

31st Annual UMass Chan Research Retreat

October 14-15, 2026

Worcester

Conference

2026 IPO Annual Meeting

September 27-29, 2026

Toronto

Seminar

IAM and WTR Live: Australasia IP Forum 2026

August 11, 2026

Melbourne

Conference

Finnegan IP Summit 2026: Celebrating an Inclusive Talent Pipeline

August 11-13, 2026

Washington, DC

Conference

13th Annual Summit for Women Leaders in Life Sciences Law

July 29-30, 2026

Boston

Webinar

Successful Strategies to Win Alice Motions and Fee Awards in Patent Cases Against Non-Practicing Entities

July 22, 2026

Webinar

Webinar

Early Motions in Trade Secret Litigation – Offensive and Defensive Insights

July 15, 2026

Webinar

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP